| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 8,2 € | -100.0% | 203,1 k € | -91.9% | 2,5 M € | -76.1% | 10,5 M € | ||||||||||||||||
| EBITDA | -9,2 k € | +22.4% | -11,9 k € | +1.1% | -12,0 k € | -29.2% | -9,3 k € | +4.1% | -9,7 k € | -2.1% | -9,5 k € | +0.0% | -9,5 k € | -15.4% | -8,3 k € | +20.1% | -10,3 k € | -3.2% | -10,0 k € | +89.7% | -97,5 k € | +24.7% | -129,5 k € | -13.8% | -113,8 k € | +70.0% | -378,8 k € | -296.3% | -95,6 k € | -16.9% | -81,8 k € | +73.2% | -304,8 k € | +57.1% | -710,1 k € | +82.9% | -4,2 M € | |
| Operating profit | -9,2 k € | +22.4% | -11,9 k € | +1.1% | -12,0 k € | -29.2% | -9,3 k € | +4.1% | -9,7 k € | -2.1% | -9,5 k € | +0.0% | -9,5 k € | -15.4% | -8,3 k € | +20.1% | -10,3 k € | +94.3% | -179,9 k € | -84.1% | -97,7 k € | +23.5% | -127,8 k € | -12.1% | -114,0 k € | -11.6% | -102,1 k € | -6.6% | -95,8 k € | -14.7% | -83,5 k € | +74.0% | -321,3 k € | +85.2% | -2,2 M € | +52.0% | -4,5 M € | |
| Profit/loss | 1,0 M € | -18.8% | 1,3 M € | -27.7% | 1,8 M € | +111.5% | 843,9 k € | +26.6% | 666,5 k € | -13.2% | 767,8 k € | -10.5% | 857,7 k € | +2.5% | 837,1 k € | +12.8% | 742,4 k € | +57.4% | 471,6 k € | -22.8% | 610,6 k € | -7.6% | 660,9 k € | -26.2% | 895,5 k € | -14.5% | 1,0 M € | -14.0% | 1,2 M € | +20.1% | 1,0 M € | -51.9% | 2,1 M € | +183.6% | -2,5 M € | +52.8% | -5,3 M € | |
| Equity | 35,9 M € | +3.0% | 34,9 M € | +3.8% | 33,6 M € | -0.6% | 33,8 M € | -6.0% | 36,0 M € | +1.9% | 35,3 M € | +2.2% | 34,5 M € | +2.5% | 33,7 M € | +2.5% | 32,8 M € | +2.3% | 32,1 M € | +1.5% | 31,6 M € | -18.9% | 39,0 M € | +1.7% | 38,4 M € | +2.4% | 37,5 M € | +2.9% | 36,4 M € | +3.5% | 35,2 M € | +3.0% | 34,2 M € | +6.6% | 32,1 M € | +351.9% | 7,1 M € | |
| Total assets | 36,0 M € | +2.6% | 35,1 M € | -1.9% | 35,8 M € | -2.9% | 36,8 M € | +2.3% | 36,0 M € | +1.9% | 35,3 M € | +2.2% | 34,5 M € | +2.5% | 33,7 M € | +2.5% | 32,9 M € | +2.3% | 32,1 M € | +1.4% | 31,7 M € | -18.9% | 39,1 M € | +1.7% | 38,4 M € | -10.0% | 42,7 M € | +0.0% | 42,7 M € | +0.2% | 42,6 M € | -1.3% | 43,1 M € | +31.3% | 32,9 M € | +232.0% | 9,9 M € | |
| Cash | 5,0 M € | +21.9% | 4,1 M € | -14.1% | 4,8 M € | -18.2% | 5,9 M € | +16.6% | 5,1 M € | +19.0% | 4,2 M € | +71.8% | 2,5 M € | -23.7% | 3,2 M € | +36.8% | 2,4 M € | +59.3% | 1,5 M € | +55.5% | 956,8 k € | -88.6% | 8,4 M € | +132.4% | 3,6 M € | +35623.5% | 10,1 k € | — | 153,8 k € | +108.5% | 73,7 k € | -90.5% | 773,5 k € | -48.2% | 1,5 M € | |||
| Debts | 37,5 k € | -79.5% | 183,2 k € | -91.5% | 2,2 M € | -28.2% | 3,0 M € | +41194.8% | 7,3 k € | +1.8% | 7,2 k € | +4.0% | 6,9 k € | -27.0% | 9,4 k € | -4.9% | 9,9 k € | +161.0% | 3,8 k € | -87.3% | 29,8 k € | -19.5% | 37,0 k € | -28.9% | 52,1 k € | -99.0% | 5,2 M € | -16.6% | 6,3 M € | -15.3% | 7,4 M € | -17.4% | 9,0 M € | +1049.0% | 780,2 k € | -72.1% | 2,8 M € | |
| Staff | — | — | — | — | — | — | — | — | — | — | 1 | 1 | 1 | 1 | 1 | 1 | 1,2 | 8 | 15,3 | |||||||||||||||||||
Public limited company · Nazareth-De Pinte · incorporated on 19/10/1990
Public limited company profitable and well capitalised. Cash position rising (+21.9%).
Solid counterparty for a standard engagement.
ABC DENTAL AND PHARMACEUTICAL CONSULTANCY is a Public limited company incorporated in 1990. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Nazareth-De Pinte.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette